BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
193 hedge funds and large institutions have $2.53B invested in bluebird bio in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 49 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less call options, than puts
Call options by funds: $39.2M | Put options by funds: $52M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
193
Holding in Top 10
3
Calls
$39.2M
Puts
$52M
Top Buyers
| 1 | +$48.9M | |
| 2 | +$42.9M | |
| 3 | +$32.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$21.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$17.9M |
Top Sellers
| 1 | -$52.7M | |
| 2 | -$41.3M | |
| 3 | -$28.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$17.1M |